Search Results - Rute Castro
- Showing 1 - 7 results of 7
-
1
-
2
Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81 by Hugo R. Soares, Rute Castro, Hélio A. Tomás, Manuel J. T. Carrondo, Paula M. Alves, Ana S. Coroadinha
Published in AMB Express (2019-02-01)Get full text
Article -
3
Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate by Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, Patrícia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves, Sylvain Fleury, António Roldão
Published in Pharmaceutics (2022-04-01)Get full text
Article -
4
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors by Gabriela Silva, Ana F. Rodrigues, Susana Ferreira, Carolina Matos, Rute P. Eleutério, Gonçalo Marques, Khrystyna Kucheryava, Ana R. Lemos, Pedro M. F. Sousa, Rute Castro, Ana Barbas, Daniel Simão, Paula M. Alves
Published in Biomolecules (2023-03-01)Get full text
Article -
5
Streamlined purification of ADDomer nanoparticles for scalable biomanufacturing by Raquel Arinto-Garcia, Cláudia S. Paiva, Emerson Bryan Dilla, Dirk E. Martens, Justin Sargunas, Michael Betenbaugh, Dora Buzas, Georgia Balchin, Mafalda Moleirinho, Rute Castro, Cristina Peixoto, Imre Berger, Christiane Schaffitzel, Paula M. Alves, António Roldão
Published in Journal of Biological Engineering (2025-09-01)Get full text
Article -
6
Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate by Bárbara Fernandes, Bárbara Fernandes, Marcos Sousa, Marcos Sousa, Rute Castro, Anja Schäfer, Anja Schäfer, Julia Hauser, Julia Hauser, Kai Schulze, Mario Amacker, Mario Amacker, Marco Tamborrini, Marco Tamborrini, Gerd Pluschke, Gerd Pluschke, Paula M Alves, Paula M Alves, Sylvain Fleury, António Roldão, António Roldão
Published in Frontiers in Bioengineering and Biotechnology (2022-05-01)Get full text
Article -
7
Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges by João Faro-Viana, Marie-Louise Bergman, Lígia A. Gonçalves, Nádia Duarte, Teresa P. Coutinho, Patrícia C. Borges, Christian Diwo, Rute Castro, Paula Matoso, Vanessa Malheiro, Ana Brennand, Lindsay Kosack, Onome Akpogheneta, João M. Figueira, Conceição Cardoso, Ana M. Casaca, Paula M. Alves, Telmo Nunes, Carlos Penha-Gonçalves, Jocelyne Demengeot
Published in Nature Communications (2022-01-01)Get full text
Article
